Review
Published on 13 Jan 2023
Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1017787
- 12,444 views
- 9 citations
Type at least 3 characters
2,053 articles
articles
Case Report
Published on 12 Jan 2023
Case report: A case of classic hairy cell leukemia with CNS involvement treated with vemurafenib
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1100577
- 5,127 views
- 8 citations
Original Research
Published on 12 Jan 2023
Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1020566
- 5,827 views
- 15 citations
Systematic Review
Published on 12 Jan 2023
Harnessing the immune system in the treatment of cutaneous T cell lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1071171
- 5,361 views
- 3 citations
Case Report
Published on 10 Jan 2023
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1100105
- 4,036 views
- 2 citations
Original Research
Published on 09 Jan 2023
Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1085672
- 5,717 views
- 4 citations
Case Report
Published on 09 Jan 2023
Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1028651
- 3,878 views
- 12 citations
Original Research
Published on 06 Jan 2023
Age-period-cohort analysis of gender differential trends in incidence and mortality of non-Hodgkin lymphoma in China, 1990-2019
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1056030
- 3,699 views
- 9 citations
Review
Published on 05 Jan 2023
Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1082235
- 6,716 views
- 9 citations
Opinion
Published on 04 Jan 2023
Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1098375
- 13,327 views
- 4 citations
Original Research
Published on 04 Jan 2023
Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1056786
- 2,719 views
- 7 citations
Original Research
Published on 04 Jan 2023
Comparison of characteristics and outcomes on ETP-ALL/LBL and non-ETP ALL patients receiving allogeneic hematopoietic stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1025885
- 3,858 views
- 7 citations
Case Report
Published on 04 Jan 2023
Case report: Rosai-Dorfman disease with rare extranodal lesions in the pelvis, heart, liver and skin
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1083500
- 3,118 views
- 4 citations
Review
Published on 04 Jan 2023
Role of Notch2 pathway in mature B cell malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1073672
- 6,515 views
- 9 citations
Systematic Review
Published on 29 Dec 2022
Efficacy and safety of CD22-specific and CD19/CD22-bispecific CAR-T cell therapy in patients with hematologic malignancies: A systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.954345
- 4,931 views
- 11 citations
Original Research
Published on 23 Dec 2022
Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1062065
- 5,337 views
- 6 citations
Systematic Review
Published on 23 Dec 2022
Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1063689
- 3,874 views
- 1 citation
Editorial
Published on 22 Dec 2022
Editorial: Reviews in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1105523
- 2,595 views
Case Report
Published on 21 Dec 2022
A case report of synchronous triple primary malignancies: Diffuse large B-cell lymphoma, rectal adenocarcinoma and hepatocellular carcinoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1046878
- 3,216 views
- 2 citations
Original Research
Published on 20 Dec 2022
The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1084683
- 5,403 views
- 7 citations
Original Research
Published on 20 Dec 2022
The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1009993
- 3,102 views
- 2 citations
Review
Published on 20 Dec 2022
Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1099265
- 9,027 views
- 9 citations
Original Research
Published on 20 Dec 2022
Systematic discrimination of the repetitive genome in proximity of ferroptosis genes and a novel prognostic signature correlating with the oncogenic lncRNA CRNDE in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1026153
- 4,666 views
- 8 citations
Review
Published on 19 Dec 2022
Cancer-associated fibroblasts in acute leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1022979
- 5,225 views
- 9 citations